Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling.

Long X, Xiong W, Zeng X, Qi L, Cai Y, Mo M, Jiang H, Zhu B, Chen Z, Li Y.

Cell Death Dis. 2019 May 10;10(5):375. doi: 10.1038/s41419-019-1581-6.

2.

Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.

Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, Chang C.

Oncotarget. 2015 Sep 22;6(28):26065-78. doi: 10.18632/oncotarget.4569.

3.

Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.

Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Zuo L, Guancial EA, Messing EM, Chang C, Yeh S.

Cancer Lett. 2018 Aug 28;430:215-223. doi: 10.1016/j.canlet.2018.03.045. Epub 2018 Apr 22.

PMID:
29684419
4.

Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.

Yeh CR, Hsu I, Song W, Chang H, Miyamoto H, Xiao GQ, Li L, Yeh S.

Am J Cancer Res. 2015 Feb 15;5(3):1146-57. eCollection 2015.

5.

Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.

Hsu I, Chuang KL, Slavin S, Da J, Lim WX, Pang ST, O'Brien JH, Yeh S.

Carcinogenesis. 2014 Mar;35(3):651-61. doi: 10.1093/carcin/bgt348. Epub 2013 Oct 22.

PMID:
24148819
6.

Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals.

Rao Q, Chen Y, Yeh CR, Ding J, Li L, Chang C, Yeh S.

Oncotarget. 2016 Feb 16;7(7):7842-55. doi: 10.18632/oncotarget.5467.

7.

Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.

Zhang H, Xie C, Yue J, Jiang Z, Zhou R, Xie R, Wang Y, Wu S.

Mol Carcinog. 2017 Mar;56(3):1150-1163. doi: 10.1002/mc.22581. Epub 2016 Dec 13.

PMID:
27769097
8.

Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.

Zhang D, Ding L, Li Y, Ren J, Shi G, Wang Y, Zhao S, Ni Y, Hou Y.

Sci Rep. 2017 Nov 24;7(1):16231. doi: 10.1038/s41598-017-13431-y.

9.

Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling.

Yan H, Guo BY, Zhang S.

Biochem Biophys Res Commun. 2016 Feb 19;470(4):947-54. doi: 10.1016/j.bbrc.2016.01.131. Epub 2016 Jan 27.

PMID:
26826383
10.

Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.

Yi Y, Zeng S, Wang Z, Wu M, Ma Y, Ye X, Zhang B, Liu H.

Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):793-803. doi: 10.1016/j.bbadis.2017.12.021. Epub 2017 Dec 16.

11.

CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.

Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, Konishi N, Toritsuka M, Kishimoto T, Rosser CJ, Fujimoto K.

Neoplasia. 2016 Oct;18(10):636-646. doi: 10.1016/j.neo.2016.08.002. Epub 2016 Sep 28. Erratum in: Neoplasia. 2017 Mar;19(3):250-251.

12.

Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression.

Xu L, Deng Q, Pan Y, Peng M, Wang X, Song L, Xiao M, Wang Z.

Int J Mol Med. 2014 Jan;33(1):91-6. doi: 10.3892/ijmm.2013.1549. Epub 2013 Nov 7.

PMID:
24212330
13.

IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.

Shintani Y, Fujiwara A, Kimura T, Kawamura T, Funaki S, Minami M, Okumura M.

J Thorac Oncol. 2016 Sep;11(9):1482-92. doi: 10.1016/j.jtho.2016.05.025. Epub 2016 Jun 8.

14.

Significance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancer.

An J, Enomoto A, Weng L, Kato T, Iwakoshi A, Ushida K, Maeda K, Ishida-Takagishi M, Ishii G, Ming S, Sun T, Takahashi M.

J Cancer Res Clin Oncol. 2013 Mar;139(3):379-88. doi: 10.1007/s00432-012-1328-6. Epub 2012 Oct 30.

PMID:
23108890
15.

Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner.

Sun Y, Guan Z, Zhao W, Jiang Y, Li Q, Cheng Y, Xu Y.

Int J Oncol. 2017 Oct;51(4):1219-1226. doi: 10.3892/ijo.2017.4089. Epub 2017 Aug 2.

PMID:
28791405
16.

HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.

Sun Y, Guan Z, Liang L, Cheng Y, Zhou J, Li J, Xu Y.

Oncol Rep. 2016 Mar;35(3):1549-56. doi: 10.3892/or.2015.4536. Epub 2015 Dec 29.

PMID:
26717965
17.

Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.

Liao JK, Zhou B, Zhuang XM, Zhuang PL, Zhang DM, Chen WL.

Biomed Pharmacother. 2018 Jan;97:1341-1348. doi: 10.1016/j.biopha.2017.11.024. Epub 2017 Nov 14.

PMID:
29156523
18.

mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.

Li J, Guan J, Long X, Wang Y, Xiang X.

Oncol Rep. 2016 Jun;35(6):3523-31. doi: 10.3892/or.2016.4714. Epub 2016 Mar 29.

PMID:
27035564
19.

Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.

Shen Z, Qin X, Yan M, Li R, Chen G, Zhang J, Chen W.

Oncotarget. 2017 Jan 3;8(1):1290-1303. doi: 10.18632/oncotarget.13609.

20.

Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs.

Gok Yavuz B, Gunaydin G, Gedik ME, Kosemehmetoglu K, Karakoc D, Ozgur F, Guc D.

Sci Rep. 2019 Feb 28;9(1):3172. doi: 10.1038/s41598-019-39553-z.

Supplemental Content

Support Center